JN Nova Pharma Inc.

Profile

JN Nova Pharma is developing novel therapeutics to address a particular group of Long COVID patients, who are affected by respiratory and kidney-related diseases. JN Nova Pharma has completed GMP manufacturing and toxicology studies and is preparing the Clinical Trial Application package for Phase I studies.

jn nova pharma inc.

Website

jnnova.com

Contact


Event details

Date: June 3 - 6, 2024

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

41 in total